Geode Capital Management
OKUR icon

Geode Capital Management’s OnKure Therapeutics OKUR Stock Holding History

Geode Capital Management’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.96M Sell
720,248
-4,190
-0.6% -$15.8K ﹤0.01% 3173
2026
Q2 		$3.3M Buy
724,438
+625,688
+634% +$2.68M ﹤0.01% 3075
2026
Q1 		$409K Buy
98,750
+21,281
+27% +$65.7K ﹤0.01% 3656
2025
Q4 		$225K Sell
77,469
-7,426
-9% -$22.2K ﹤0.01% 3862
2025
Q3 		$233K Hold
84,895
– – ﹤0.01% 3872
2025
Q2 		$203K Sell
84,895
-1,416
-2% -$3.71K ﹤0.01% 3865
2025
Q1 		$371K Buy
86,311
+9,712
+13% +$54.6K ﹤0.01% 3652
2024
Q4 		$659K Buy
76,599
+55,149
+257% +$835K ﹤0.01% 3517
2024
Q3 		$365K Buy
21,450
+1,346
+7% +$19.9K ﹤0.01% 3702
2024
Q2 		$304K Sell
20,104
-13,166
-40% -$223K ﹤0.01% 3761
2024
Q1 		$552K Sell
33,270
-684
-2% -$11.3K ﹤0.01% 3574
2023
Q4 		$543K Buy
33,954
+891
+3% +$55.5K ﹤0.01% 3581
2023
Q3 		$2.52M Buy
33,063
+3,617
+12% +$246K ﹤0.01% 2989
2023
Q2 		$1.93M Buy
29,446
+19,785
+205% +$1.59M ﹤0.01% 3125
2023
Q1 		$578K Buy
9,661
+830
+9% +$30.1K ﹤0.01% 3586
2022
Q4 		$205K Sell
8,831
-19
-0.2% -$504 ﹤0.01% 4082
2022
Q3 		$296K Buy
8,850
+3,514
+66% +$115K ﹤0.01% 3997
2022
Q2 		$141K Sell
5,336
-6,780
-56% -$158K ﹤0.01% 4438
2022
Q1 		$356K Buy
12,116
+192
+2% +$10.7K ﹤0.01% 4115
2021
Q4 		$1.02M Sell
11,924
-143
-1% -$10.5K ﹤0.01% 3714
2021
Q3 		$898K Buy
12,067
+4,860
+67% +$412K ﹤0.01% 3737
2021
Q2 		$672K Buy
+7,207
New +$804K ﹤0.01% 3796

Other funds holding OKUR

Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Police & Firemen's Retirement System of New Jersey
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13B AUM 35.88% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Geode Capital Management's OKUR Position: Q3 2026 in Review

Geode Capital Management reduced its OnKure Therapeutics (OKUR) stake by 0.58% in Q3 2026, selling an estimated $15.8K and leaving 720,248 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #3173.

Geode Capital Management first reported a position in OKUR in Q2 2021 and has held it in 22 quarters since. The position peaked at $3.3M in Q2 2026. 14 funds tracked by Wall St. Rank hold OKUR as of Q3 2026.

  • Geode Capital Management held 720,248 shares of OnKure Therapeutics worth $1.96M as of Q3 2026.
  • Geode Capital Management sold 4,190 OnKure Therapeutics shares in Q3 2026, an estimated $15.8K.
  • OnKure Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3173 holding.
  • Geode Capital Management first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 22 quarters since.
  • Geode Capital Management's OnKure Therapeutics position peaked at $3.3M in Q2 2026.
  • 14 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.